Remington-Davis Clinical Research — Columbus, Ohio

Public research footprint of Remington-Davis Clinical Research, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Erythropoietic Protoporphyria (EPP) · Chronic Obstructive Pulmonary Disease · X-Linked Protoporphyria (XLP) · Autosomal Dominant Polycystic Kidney

Recently updated registry entries

NCT06012240 — A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… (Recruiting)
NCT06910358 — Study of Bitopertin in Participants With EPP or XLP (APOLLO) (Active Not Recruiting)
NCT07064473 — EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Remington-Davis Clinical Research?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.